indications for glp 1 agonist GLP-1 receptor agonists GLP-1 Medications for Weight Loss:
Description
10.20471/acc.2019.58.02.06 [DOI] [PMC free article] [PubMed] [Google Scholar] Berridge, K
Prescribing of the compounds must be based upon the professional judgment of the licensed health care provider after considering the patients unique medical condition and factors including body weight, size and overall health status
Recent Developments: Roche - Acquisition (December 2023): Roche acquired Carmot Therapeutics, adding dual GLP-1/GIP agonist assets to its pipeline, positioning to compete with Novo Nordisk and Eli Lilly in obesity [1]
Patients who maintain or build muscle during GLP-1 treatment experience less metabolic slowdown and better weight maintenance after stopping
